Posted by Michael Wonder on 04 Dec 2018
The Trump administration has a new idea for changing drug rebates. That doesn’t mean it’s abandoning its earlier proposals.
4 December 2018 - The Trump administration announced last week that, in an effort to lower drug costs for seniors, some “rebates” would be passed on to Medicare recipients at the pharmacy counter.
At first blush, it sounded like a new version of the administration’s previous pledge to upend the pharmacy benefit manager industry and the system of “rebates,” which lawmakers and drug makers have blamed for high prices. It got some lobbyists wondering if the administration was pushing this small change in lieu of a more grandiose proposal.
